The value we create

As a global pharmaceutical company, we play an important role in contributing to the health and well-being of people. Our sustainable business model creates long-term value for our key stakeholders.

47% Employees 2020: R8 019 million

(2019: R7 942 million)

36%

Reinvested 2020: R6 149 million

(2019: R1 101 million)

10%

Providers of capital 2020: R1 614 million (2019: R3 809 million)

7% Governments 2020: R1 222 million

(2019: R1 161 million)

Patients and healthcare providers

Improving health and quality of life for patients that use our medicines Provision of quality and affordable treatment options and medicines to patients, healthcare professionals and healthcare systems

Our employees

Providing employment and opportunities for growth and development in the geographic regions in which we operate Diverse and inclusive working environment, free of discrimination and harassment

Communities in which we operate

Contribution to society through engagement with civil society and investment in SED Responsible management of our impact on the environment

Our investors and funders

Sustainable returns to shareholders Servicing and repayment of debt

Our suppliers and business partners

Economic stimulus through procurement of goods and services Collaboration and partnering opportunities

Governments and pharmaceutical regulatory bodies

Contribution to governments through taxes Contribute to effective healthcare systems through pharmaceutical regulatory compliance in the countries in which we operate